CoreWeave Forecast, price target & analysts
CoreWeave Target price 2026 - Analyst rating & recommendation
CoreWeave Classifications & Recommendation
CoreWeave Price Target
| Target Price | $153.00 |
| Price | $55.19 |
| Potential | 177.22% |
| Number of Estimates | 42 |
| 42 Analysts have issued a price target CoreWeave 2027 . The average CoreWeave target price is $153.00. This is 177.22% higher than the current stock price. The highest price target is $318.15 476.46% , the lowest is $39.39 28.63% . | |
| A rating was issued by 46 analysts: 32 Analysts recommend CoreWeave to buy, 12 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CoreWeave stock has an average upside potential 2027 of 177.22% . Most analysts recommend the CoreWeave stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
47 Analysts have issued a sales forecast CoreWeave 2026 . The average CoreWeave sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
40 Analysts have issued an CoreWeave EBITDA forecast 2026. The average CoreWeave EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
45 CoreWeave Analysts have issued a net profit forecast 2026. The average CoreWeave net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current CoreWeave Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 23 2026 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 23 2026 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 21 2026 |
| HSBC |
Reduce
➜
Reduce
|
Unchanged | Oct 20 2026 |
| Goldman Sachs |
Neutral
➜
Buy
|
Upgrade | Oct 19 2026 |
| Mizuho |
Neutral
➜
Neutral
|
Unchanged | Oct 15 2026 |
| Freedom Capital Markets |
Buy
➜
Buy
|
Unchanged | Oct 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 23 2026 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 23 2026 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 21 2026 |
|
Unchanged
HSBC:
Reduce
➜
Reduce
|
Oct 20 2026 |
|
Upgrade
Goldman Sachs:
Neutral
➜
Buy
|
Oct 19 2026 |
|
Unchanged
Mizuho:
Neutral
➜
Neutral
|
Oct 15 2026 |
|
Unchanged
Freedom Capital Markets:
Buy
➜
Buy
|
Oct 05 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
